Bionik Laboratories Corp. (OTCMKTS:BNKL) Files An 8-K Regulation FD Disclosure
Item 7.01
| Regulation FD Disclosure |
Bionik Laboratories Corp. (the Registrant) is furnishing
presentation materials included as Exhibit 99.1 to this report to
Item 7.01 of Form 8-K. The Registrant is not undertaking to
update this presentation. The information in this report
(including Exhibit 99.1) is being furnished to Item 7.01 and
shall not be deemed to be filed for the purposes of Section 18 of
the Securities Exchange Act of 1934, as amended, or otherwise
subject to the liabilities of that section. This report will not
be deemed an admission as to the materiality of any information
herein (including Exhibit 99.1).
| Item 9.01 | Financial Statements and Exhibits |
(d) Exhibits
| Exhibit No. | Description |
| 99.1 | Presentation Materials |
About Bionik Laboratories Corp. (OTCMKTS:BNKL)
Bionik Laboratories Corp. (Bionik), formerly Drywave Technologies, Inc., is a medical device and robotics company. The Company is focused on providing rehabilitation solutions and developing transformational technologies and solutions to individuals with neurological disorders, specializing in the designing, developing and commercializing of physical rehabilitation technologies, prosthetics and assisted robotic products. It has over three products on the market and approximately three products in various stages of development. The InMotion Systems include the InMotion ARM, InMotion HAND, InMotion Wrist and InMotion ANKLE are designed to provide patent-adaptive therapy in a manner that has been clinically verified to manage neuro-recovery. The Company is also engaged in developing a lower-body exoskeleton, ARKE, which designs to allow paraplegics, as well as other wheelchair users the ability to rehabilitate through walking. Bionik Laboratories Corp. (OTCMKTS:BNKL) Recent Trading Information
Bionik Laboratories Corp. (OTCMKTS:BNKL) closed its last trading session down -0.010 at 0.740 with 2,000 shares trading hands.
